Agents ciblé vers la plectine-1 de façon à détecter et traiter l'adénocarcinome du conduit pancréatique

• 收藏
• 分享

专利权人:

The General Hospital Corporation

发明人:

申请号：

EP14190585.1

公开号：

EP2862871A1

申请日:

2009.04.14

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

Described herein are compositions and methods for cancer cell biomarkers, such as pancreatic ductal adenocarcinoma (PDAC) cell biomarkers, and binding molecules for diagnosis and treatment of cancer, e.g., PDAC. Methods of identifying "accessible" proteomes are disclosed for identifying cancer biomarkers, such as plectin-1, a PDAC biomarker. Additionally, imaging compositions are provided comprising magnetofluorescent nanoparticles conjugated to peptide ligands for identifying PDACs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/